Pullan L M
Central Nervous System Disease Research, G.D. Searle & Co., St Louis, Missouri 63198.
Neuropharmacology. 1988 May;27(5):493-7. doi: 10.1016/0028-3908(88)90131-1.
Phencyclidine inhibited the flux of 22Na from hippocampal slices of the rat stimulated by N-methyl-D-aspartate (NMDA) in a concentration-dependent manner and consistent with the subclass of excitatory amino acid receptors, with a close interaction between NMDA and phencyclidine receptors. The inhibition by phencyclidine of the NMDA-stimulated flux of 22Na was non-competitive, in contrast to that produced by D-2-amino-5-phosphonovalerate. Other compounds which produce stereotyped behavior in vivo also inhibited the NMDA-stimulated flux of 22Na and the rank of the percentage inhibition of the NMDA-stimulated flux correlated with the affinities at the phencyclidine receptor with 97% confidence. The structural diversity and selectivity for the phencyclidine receptor of those compounds which inhibited the NMDA-stimulated flux of 22Na argue that the interaction was at the phencyclidine receptor. The presence of magnesium did not alter the relative magnitude of inhibition by phencyclidine, suggesting that the phencyclidine site is separate from the pressumably, channel-blocking magnesium site. Thus, the data of the present study support a model where the phencyclidine site is separate from the NMDA recognition site and from the presumed channel-blocking site of magnesium within the NMDA-associated ion channel.
苯环利定以浓度依赖性方式抑制N-甲基-D-天冬氨酸(NMDA)刺激的大鼠海马切片中22Na的通量,这与兴奋性氨基酸受体亚类一致,且NMDA与苯环利定受体之间存在密切相互作用。与D-2-氨基-5-磷酸戊酸所产生的抑制作用不同,苯环利定对NMDA刺激的22Na通量的抑制作用是非竞争性的。其他在体内产生刻板行为的化合物也抑制NMDA刺激的22Na通量,并且NMDA刺激通量的抑制百分比排名与苯环利定受体的亲和力相关,置信度为97%。那些抑制NMDA刺激的22Na通量的化合物对苯环利定受体的结构多样性和选择性表明这种相互作用发生在苯环利定受体上。镁的存在并未改变苯环利定的相对抑制程度,这表明苯环利定位点与推测的通道阻断镁位点是分开的。因此,本研究的数据支持这样一种模型,即苯环利定位点与NMDA识别位点以及NMDA相关离子通道内推测的镁通道阻断位点是分开的。